Clinical Trial Update: Atorvastatin in Treating Patients With Stage IIb-III Triple Negative Breast Cancer Who Did Not Achieve a Pathologic Complete Response After Receiving Neoadjuvant Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial update on atorvastatin in patients with stage IIb-III triple-negative breast cancer who did not achieve pathologic complete response after neoadju…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 | Phase 2 | Status: TERMINATED | Results posted: 2024-10-02